These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 29384229)
1. Computational Study of the Aza-Michael Addition of the Flavonoid (+)-Taxifolin in the Inhibition of β-Amyloid Fibril Aggregation. Ginex T; Trius M; Luque FJ Chemistry; 2018 Apr; 24(22):5813-5824. PubMed ID: 29384229 [TBL] [Abstract][Full Text] [Related]
2. Site-specific inhibitory mechanism for amyloid β42 aggregation by catechol-type flavonoids targeting the Lys residues. Sato M; Murakami K; Uno M; Nakagawa Y; Katayama S; Akagi K; Masuda Y; Takegoshi K; Irie K J Biol Chem; 2013 Aug; 288(32):23212-24. PubMed ID: 23792961 [TBL] [Abstract][Full Text] [Related]
3. Structural insights into mechanisms for inhibiting amyloid β42 aggregation by non-catechol-type flavonoids. Hanaki M; Murakami K; Akagi K; Irie K Bioorg Med Chem; 2016 Jan; 24(2):304-13. PubMed ID: 26719209 [TBL] [Abstract][Full Text] [Related]
4. Three Structural Features of Functional Food Components and Herbal Medicine with Amyloid β42 Anti-Aggregation Properties. Murakami K; Irie K Molecules; 2019 Jun; 24(11):. PubMed ID: 31195683 [TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship for (+)-taxifolin isolated from silymarin as an inhibitor of amyloid β aggregation. Sato M; Murakami K; Uno M; Ikubo H; Nakagawa Y; Katayama S; Akagi K; Irie K Biosci Biotechnol Biochem; 2013; 77(5):1100-3. PubMed ID: 23649236 [TBL] [Abstract][Full Text] [Related]
6. A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling. Gu L; Tran J; Jiang L; Guo Z J Struct Biol; 2016 Apr; 194(1):61-7. PubMed ID: 26827680 [TBL] [Abstract][Full Text] [Related]
7. Taxifolin inhibits amyloid-β oligomer formation and fully restores vascular integrity and memory in cerebral amyloid angiopathy. Saito S; Yamamoto Y; Maki T; Hattori Y; Ito H; Mizuno K; Harada-Shiba M; Kalaria RN; Fukushima M; Takahashi R; Ihara M Acta Neuropathol Commun; 2017 Apr; 5(1):26. PubMed ID: 28376923 [TBL] [Abstract][Full Text] [Related]
8. Flavonoids with Vicinal Hydroxyl Groups Inhibit Human Calcitonin Amyloid Formation. Lantz R; Busbee B; Wojcikiewicz EP; Du D Chemistry; 2020 Oct; 26(57):13063-13071. PubMed ID: 32458489 [TBL] [Abstract][Full Text] [Related]
9. The regioselectivity of glutathione adduct formation with flavonoid quinone/quinone methides is pH-dependent. Awad HM; Boersma MG; Boeren S; van Bladeren PJ; Vervoort J; Rietjens IM Chem Res Toxicol; 2002 Mar; 15(3):343-51. PubMed ID: 11896681 [TBL] [Abstract][Full Text] [Related]
10. N-Terminus Binding Preference for Either Tanshinone or Analogue in Both Inhibition of Amyloid Aggregation and Disaggregation of Preformed Amyloid Fibrils-Toward Introducing a Kind of Novel Anti-Alzheimer Compounds. Dong M; Zhao W; Hu D; Ai H; Kang B ACS Chem Neurosci; 2017 Jul; 8(7):1577-1588. PubMed ID: 28406293 [TBL] [Abstract][Full Text] [Related]
11. Metal binding of flavonoids and their distinct inhibition mechanisms toward the oxidation activity of Cu2+-β-amyloid: not just serving as suicide antioxidants! Tay WM; da Silva GF; Ming LJ Inorg Chem; 2013 Jan; 52(2):679-90. PubMed ID: 23301941 [TBL] [Abstract][Full Text] [Related]
12. Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations. Nguyen P; Derreumaux P Acc Chem Res; 2014 Feb; 47(2):603-11. PubMed ID: 24368046 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of HEWL fibril formation by taxifolin: Mechanism of action. Mahdavimehr M; Meratan AA; Ghobeh M; Ghasemi A; Saboury AA; Nemat-Gorgani M PLoS One; 2017; 12(11):e0187841. PubMed ID: 29131828 [TBL] [Abstract][Full Text] [Related]
14. Disclosure of a fundamental clue for the elucidation of the myricetin mechanism of action as amyloid aggregation inhibitor by mass spectrometry. Fiori J; Naldi M; Bartolini M; Andrisano V Electrophoresis; 2012 Nov; 33(22):3380-6. PubMed ID: 22961751 [TBL] [Abstract][Full Text] [Related]
15. Mechanistic analyses of the suppression of amyloid β42 aggregation by apomorphine. Hanaki M; Murakami K; Katayama S; Akagi KI; Irie K Bioorg Med Chem; 2018 May; 26(8):1538-1546. PubMed ID: 29429575 [TBL] [Abstract][Full Text] [Related]
16. The membrane-active amphibian peptide caerin 1.8 inhibits fibril formation of amyloid β1-42. Liu Y; Wang T; Calabrese AN; Carver JA; Cummins SF; Bowie JH Peptides; 2015 Nov; 73():1-6. PubMed ID: 26275335 [TBL] [Abstract][Full Text] [Related]
17. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters. Matsuzaki K Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558 [TBL] [Abstract][Full Text] [Related]
18. Inhibition by flavonoids of amyloid-like fibril formation by Plasmodium falciparum merozoite surface protein 2. Chandrashekaran IR; Adda CG; MacRaild CA; Anders RF; Norton RS Biochemistry; 2010 Jul; 49(28):5899-908. PubMed ID: 20545323 [TBL] [Abstract][Full Text] [Related]
19. Structural requirements for the flavonoid fisetin in inhibiting fibril formation of amyloid beta protein. Akaishi T; Morimoto T; Shibao M; Watanabe S; Sakai-Kato K; Utsunomiya-Tate N; Abe K Neurosci Lett; 2008 Oct; 444(3):280-5. PubMed ID: 18761054 [TBL] [Abstract][Full Text] [Related]
20. Concurrent Treatment with Taxifolin and Cilostazol on the Lowering of β-Amyloid Accumulation and Neurotoxicity via the Suppression of P-JAK2/P-STAT3/NF-κB/BACE1 Signaling Pathways. Park SY; Kim HY; Park HJ; Shin HK; Hong KW; Kim CD PLoS One; 2016; 11(12):e0168286. PubMed ID: 27977755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]